Suja Life (SUJA) investor relations material

Executive summary

• Net sales grew 11.6% year-over-year to $83.9 million in Q2 2026, driven by volume growth, new product distribution, and gains in both core and emerging brands.

• Adjusted EBITDA increased 50% to $14.6 million, with margin expanding to 17.5% from 13% last year.

• Net loss widened to $27.8 million, primarily due to $25.1 million in one-time IPO-related costs and $2.3 million loss on debt extinguishment.

• The company completed its IPO in May 2026, raising $173.6 million in net proceeds, which were used to pay down debt and settle incentive units.

• Outperformed the natural healthy beverage category, maintaining #1 share in cold-pressed juice and wellness shots, with expanding household penetration and spend per buyer.

Financial highlights

• Q2 net sales: $83.9 million, up 11.6% year-over-year, with Suja Core up 9.8% to $81.9 million and Emerging Brands up 61.2% to $3.0 million.

• Gross profit: $39.2 million (46.7%–46.8% margin), up 9.9% year-over-year; gross margin slightly down from 47.4% last year.

• Adjusted EBITDA: $14.6 million (17.5% margin), up from $9.8 million (13% margin) last year.

• Net loss: $27.8 million, including $25.1 million in IPO costs and $2.3 million loss on debt extinguishment.

• Cash at quarter-end: $20.6 million; total debt reduced to $163 million after IPO-related paydown.

Outlook and guidance

• FY2026 net sales guidance: $360–$369 million (10.2%–13.0% growth); Adjusted EBITDA guidance: $70–$72 million (72.8%–77.7% growth).

• Adjusted EBITDA margin expected at 19.4%–19.5% for FY2026.

• Q3 net sales expected at ~$71 million, with gross margin ~47.8% and adjusted EBITDA margin ~15.2%.

• Net interest expense forecast at $19 million; base tax rate improved to 26.1%.

• Guidance does not include potential benefits from planned refinancing.